Kazuhiro Umeda
Director Ejecutivo en M3i, Inc. .
Perfil
Kazuhiro Umeda is currently the Chief Executive Officer at M3i, Inc., Director at POC Clinical Research, Inc., and Director at PorMedTec Co., Ltd.
He previously worked as a Director at A-CUBE, Inc., Manager at Japan Asia Investment Co. Ltd.
(Private Equity), Investment & Business Development Manager at JAIC America, Inc., and Independent Outside Director at StemRIM, Inc. Mr. Umeda received his undergraduate and graduate degrees from the University of Tokyo.
Cargos activos de Kazuhiro Umeda
Empresas | Cargo | Inicio |
---|---|---|
M3i, Inc. | Director Ejecutivo | 22/03/2016 |
POC Clinical Research, Inc. | Director/Miembro de la Junta | 01/10/2015 |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Director/Miembro de la Junta | 01/12/2017 |
Antiguos cargos conocidos de Kazuhiro Umeda.
Empresas | Cargo | Fin |
---|---|---|
STEMRIM | Director/Miembro de la Junta | 29/10/2020 |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Inversor de Capital Privado | 30/10/2010 |
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd. (JAIC) is a private equity and venture capital arm of Japan Asia Investment Co., Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 31/12/2007 |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Director/Miembro de la Junta | - |
Formación de Kazuhiro Umeda.
University of Tokyo | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
STEMRIM | Commercial Services |
Empresas privadas | 6 |
---|---|
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd. (JAIC) is a private equity and venture capital arm of Japan Asia Investment Co., Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Finance |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Finance |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Health Technology |
M3i, Inc. | Finance |
POC Clinical Research, Inc. | |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |
- Bolsa de valores
- Insiders
- Kazuhiro Umeda